Patent · US Active

Pyrrolopyrrolidinone compounds

US9365576B2 · kind B2 · utility

1Cited by
13References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 22, 2013
Grant dateJun 14, 2016
Priority date
Expiry dateMay 22, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I):as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.